WHO congratulates India for National Regulatory Authority for Vaccines
India among the BRIC countries have become the principal source of generic medicines
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA issues draft guidance on abuse-deterrent opioids
Document explains FDA's current thinking about studies that should be conducted to demonstrate that a given formulation has…
Biolog’s PM technology by UK AHVLA makes discovery on TB bacterium
Research team headed by Dr Paul Wheeler
GVK Biosciences partners with Onconova Therapeutics
Joint partnership will be based in the US and will align research priorities and technological expertise
Wockhardt receives ‘Best Enterprise’ award from the Europe Business Assembly
Receives award for its achievements in the global pharmaceutical industry
US FDA, EMEA accept GE Healthcare’s review applications for [18F] Flutemetamol
New imaging agent may aid in evaluation of Alzheimer's disease
Biocon receives marketing authorisation from DCGI for novel biologic Itolizumab
Approval paves the way for the launch of Biocon’s Alzumab in India
MCC-South Africa approval opens up key African markets for Marck Biosciences
Six products from SVP facility at Kheda gets Medicines Control Council-South Africa approval
CPhI’s High Potent Drugs conference to be held in Mumbai
Presidents, directors, heads of R&D, manufacturing, formulations and containment equipment from across the globe will take…
India to exhibit greatest surge in flu vaccine demand over next decade: Global Data
Yet despite an AGR of 2.1 per cent, percentage of flu-vaccinated Indians will total a only 1.7 per cent of population by 2022